Recursion Pharmaceuticals Inc (RXRX)

04:07 AM

Recursion Pharmaceuticals Inc. (RXRX) partners with Citeline to develop AI-powered ClinTech platform - MSN

04:07 AM

Apr 12, 2026

Recursion Pharmaceuticals (RXRX) down 16.5% since last earnings report: Can it rebound? - MSN

Apr 12, 2026

Apr 11, 2026

Recursion Pharmaceuticals Stock (RXRX) Opinions on Upcoming Earnings and AI Developments - Quiver Quantitative

Apr 11, 2026

Apr 11, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 11, 2026

Apr 10, 2026

Recursion And Citeline Deepen AI Trial Data Tie For RXRX Investors - Yahoo Finance

Apr 10, 2026

Apr 10, 2026

Why Recursion (RXRX) Is Up 10.8% After Deepening Citeline Partnership To Power AI-Driven Clinical Trials - Sahm

Apr 10, 2026

Apr 10, 2026

Recursion Pharmaceuticals, Inc. (RXRX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 10, 2026

Apr 10, 2026

RXRX|Recursion Pharmaceuticals Inc|Price:3.369|Chg%:0.09 - TradingKey

Apr 10, 2026

Apr 09, 2026

Recursion Pharmaceuticals (RXRX) stock declines while market improves: Some information for investors - MSN

Apr 09, 2026

Apr 09, 2026

Recursion Pharmaceuticals, Inc. (RXRX) stock price, news, quote and history - Yahoo Finance UK

Apr 09, 2026

Apr 09, 2026

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Apr 09, 2026

Apr 08, 2026

Insider Sell Alert: Blake Borgeson Sells 30,000 Shares of Recurs - GuruFocus

Apr 08, 2026

Apr 08, 2026

Recursion names Vicki Goodman as CMO - MSN

Apr 08, 2026

Apr 07, 2026

Recursion to Participate in Upcoming Investor Conferences - marketscreener.com

Apr 07, 2026

Apr 06, 2026

Recursion Pharmaceuticals Inc. (RXRX) Partners with Citeline to Develop AI-Powered ClinTech Platform - Insider Monkey

Apr 06, 2026

Apr 05, 2026

Fund Flows: Is Recursion Pharmaceuticals Inc forming a double bottom2026 Snapshot & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Recursion Pharmaceuticals, Inc. (RXRX) latest stock news and headlines - au.finance.yahoo.com

Apr 04, 2026

Apr 03, 2026

Does AI Data Deal And New CMO Hire Change The Bull Case For Recursion (RXRX)? - Sahm

Apr 03, 2026

Apr 02, 2026

Recursion Pharmaceuticals (RXRX) beats stock market upswing: What investors need to know - MSN

Apr 02, 2026

Apr 02, 2026

Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Director at Recursion (NASDAQ: RXRX) awarded 3,268 shares - Stock Titan

Apr 02, 2026

Apr 02, 2026

Expanded Citeline Data Partnership and CMO Transition Could Be A Game Changer For Recursion Pharmaceuticals (RXRX) - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge - Sahm

Apr 02, 2026

Apr 01, 2026

1 Beaten-Down AI Stock to Buy and 1 to Avoid - Yahoo Finance

Apr 01, 2026

Mar 31, 2026

Citeline expands partnership with Recursion for clinical trials - investing.com

Mar 31, 2026

Mar 31, 2026

Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - GlobeNewswire Inc.

Mar 31, 2026

Mar 31, 2026

2 AI Healthcare Stocks to Buy Right Now - The Globe and Mail

Mar 31, 2026

Mar 31, 2026

RXRX Stock Price, Quote & Chart | RECURSION PHARMACEUTICALS-A (NASDAQ:RXRX) - ChartMill

Mar 31, 2026

Mar 29, 2026

RXRX SEC FilingsRecursion Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net

Mar 29, 2026

Mar 29, 2026

Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings - MSN

Mar 29, 2026

Mar 28, 2026

Recursion Pharmaceuticals (NASDAQ:RXRX) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Mar 28, 2026

Mar 27, 2026

Recursion Pharmaceuticals stock hits 52-week low at $2.98 By Investing.com - Investing.com Australia

Mar 27, 2026